Table 1 Antibodies used for in vivo cell depletions and cytokine neutralizations.
From: Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling
Antibody | Clone | Concentration | Administration | Target |
|---|---|---|---|---|
Anti-Ly6G | 1A8 | 225 μg/100 μl | Every 2d IP | Neutrophils |
Anti-CD8 | 116-13.1 | 400 μg/100 μl | Every 4d IP | CD8+ T cells |
Anti-CD4 | GK1.5 | 400 μg/100 μl | Every 4d IP | CD4+ T cells |
Anti-IL-17A | 17F3 | 250 μg/100 μl | Every 4d IP | Exogenous IL-17A |
Anti-IFNγ | XMG1.2 | 300 μg/100 μl | Every 4d IP | Exogenous IFNγ |
